XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Goodwill and Intangible Assets, net
 9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, net Goodwill and Intangible Assets, net
Goodwill
The Company’s goodwill balance as of September 30, 2022 was $4,123. The entire goodwill balance relates to the EPI Health Acquisition during the nine months ended September 30, 2022. None of the goodwill is expected to be deductible for income tax purposes.
Intangible Assets
The following table presents both definite and indefinite lived intangible assets as of September 30, 2022, comprised primarily of acquired product rights related to the EPI Health Acquisition:
Initial Carrying ValueAccumulated AmortizationNet Book ValueRemaining Useful Life (Years)
Rhofade$15,500 $575 $14,925 14.5
Wynzora2,000 74 1,926 14.5
Minolira8,500 315 8,185 14.5
Cloderm1,000 37 963 14.5
Sitavig2,000 111 1,889 9.5
Website domain75 — 75 — 
Total intangible assets$29,075 $1,112 $27,963 
The Company amortizes the product rights related to its commercial product portfolio over their estimated useful lives. As part of the EPI Health Acquisition, product rights were recorded at fair value as part of the Company’s ASC 805 business combination accounting. See Note 2—“Acquisition of EPI Health” for additional detail.
The following table represents annual amortization of definite lived intangible assets for the next five fiscal years, and thereafter:
2022$505 
20232,000 
20242,005 
20252,000 
20262,000 
Thereafter19,378 
Total amortization$27,888